Synovus Financial (SNV)
(Delayed Data from NYSE)
$45.43 USD
-0.68 (-1.47%)
Updated Aug 26, 2024 04:00 PM ET
After-Market: $45.52 +0.09 (0.20%) 6:22 PM ET
2-Buy of 5 2
B Value F Growth F Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$45.43 USD
-0.68 (-1.47%)
Updated Aug 26, 2024 04:00 PM ET
After-Market: $45.52 +0.09 (0.20%) 6:22 PM ET
2-Buy of 5 2
B Value F Growth F Momentum D VGM
Zacks News
Synovus' (SNV) Organic Growth Profile Aids Despite Rising Costs
by Zacks Equity Research
While balance sheet strength and asset portfolio repositioning will aid Synovus' (SNV) organic growth, rising costs and loan portfolio concentration are worrisome.
Is Synovus Financial (SNV) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here's Why Synovus (SNV) Is a Great 'Buy the Bottom' Stock Now
by Zacks Equity Research
Synovus (SNV) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Is Synovus Financial (SNV) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Can Synovus (SNV) Run Higher on Rising Earnings Estimates?
by Zacks Equity Research
Synovus (SNV) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
5 Stocks Trading Near 52-Week High That Can Climb Further
by Vasundhara Sawalka
Investors target stocks that have been on a bullish run lately. Stocks like GT, CASY, SNV, ARCH and BK that are seeing price strength have a high chance of carrying the momentum forward.
Fifth Third (FITB) Q4 Earnings Beat, Revenues Decline Y/Y
by Zacks Equity Research
An increase in fee income and lower provisions aid Fifth Third's (FITB) Q4 earnings, while higher expenses act as a headwind.
Huntington (HBAN) Q4 Earnings Beat Estimates, Revenues Dip Y/Y
by Zacks Equity Research
Huntington's (HBAN) Q4 earnings beat estimates on improvement in average loans and deposits. However, lower NII and a rise in expenses are concerning.
Bank OZK (OZK) Q4 Earnings Beat on Higher NII and Fee Income
by Zacks Equity Research
An increase in revenues, robust loans and deposit growth, and higher rates support Bank OZK's (OZK) Q4 earnings amid rising expenses and provisions.
Synovus (SNV) Stock Dips 1% as Q4 Earnings Miss Estimates
by Zacks Equity Research
Synovus' (SNV) Q4 earnings reflect a decline in revenues and loan balances, as well as an increase in expenses and provisions, while higher deposit balance offers some support.
Synovus (SNV) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Synovus (SNV) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Synovus Financial (SNV) Misses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Synovus (SNV) delivered earnings and revenue surprises of -14.89% and 7.38%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Can Huntington (HBAN) Retain Its Beat Streak in Q4 Earnings?
by Zacks Equity Research
Huntington (HBAN) is expected to have recorded a decline in net interest income in fourth-quarter 2023 due to a funding cost hike. Rising expenses and reserves are likely to have been other concerns.
Should You Buy Synovus Financial (SNV) Ahead of Earnings?
by Zacks Equity Research
Synovus Financial (SNV) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Lower NIR, Fee Income to Hurt State Street (STT) Q4 Earnings
by Zacks Equity Research
Rise in funding costs, lower interest-earning assets and muted market volatility are expected to have hurt State Street's (STT) Q4 earnings.
Analysts Estimate Regions Financial (RF) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Regions Financial (RF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Curious about Synovus (SNV) Q4 Performance? Explore Wall Street Estimates for Key Metrics
by Zacks Equity Research
Get a deeper insight into the potential performance of Synovus (SNV) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Synovus Financial (SNV) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
by Zacks Equity Research
Synovus (SNV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Best Value Stocks to Buy for January 8th
by Zacks Equity Research
QSG and SNV made it to the Zacks Rank #1 (Strong Buy) value stocks list on January 8, 2024.
Best Income Stocks to Buy for January 8th
by Zacks Equity Research
TIMB, AMKBY and SNV made it to the Zacks Rank #1 (Strong Buy) income stocks list on January 8, 2024.
Are Investors Undervaluing Bank7 (BSVN) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
4 Reasons to Add Synovus (SNV) Stock to Your Portfolio Now
by Zacks Equity Research
Driven by strong fundamentals and good growth prospects, Synovus (SNV) stock seems an attractive pick right now.
Loan Growth Aids Regions Financial (RF) Despite Cost Hike
by Zacks Equity Research
Regions Financial's (RF) NII growth will be supported by loan growth and high rates. Yet, escalating expenses and pressure on mortgage income remain woes.
Should Value Investors Buy Chemung Financial Corp (CHMG) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Synovus (SNV) Surges 7.3%: Is This an Indication of Further Gains?
by Zacks Equity Research
Synovus (SNV) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.